PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.42%
Negative revenue growth while QCOM stands at 7.69%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.96%
Negative gross profit growth while QCOM is at 31.68%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.65%
Negative EBIT growth while QCOM is at 1795.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2.38%
Negative operating income growth while QCOM is at 1795.91%. Joel Greenblatt would press for urgent turnaround measures.
21.82%
Net income growth under 50% of QCOM's 238.31%. Michael Burry would suspect the firm is falling well behind a key competitor.
14.29%
EPS growth under 50% of QCOM's 225.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
15.00%
Diluted EPS growth under 50% of QCOM's 212.50%. Michael Burry would worry about an eroding competitive position or excessive dilution.
4.86%
Share reduction more than 1.5x QCOM's 12.84%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
5.55%
Diluted share reduction more than 1.5x QCOM's 41.07%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-7.44%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
71.52%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
221.43%
Positive FCF growth while QCOM is negative. John Neff would see a strong competitive edge in net cash generation.
2.56%
10Y revenue/share CAGR under 50% of QCOM's 4584.09%. Michael Burry would suspect a lasting competitive disadvantage.
-18.47%
Negative 5Y CAGR while QCOM stands at 646.46%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-10.52%
Negative 3Y CAGR while QCOM stands at 312.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
17.47%
Below 50% of QCOM's 794.52%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
212.82%
3Y OCF/share CAGR under 50% of QCOM's 558.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
309.18%
10Y net income/share CAGR of 309.18% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
90.17%
Below 50% of QCOM's 390.29%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
346.95%
Below 50% of QCOM's 3691.54%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
112.72%
Equity/share CAGR of 112.72% while QCOM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
143.50%
5Y equity/share CAGR at 75-90% of QCOM's 187.63%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
73.87%
3Y equity/share CAGR 1.25-1.5x QCOM's 63.87%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
74.53%
Dividend/share CAGR of 74.53% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
31.98%
Dividend/share CAGR of 31.98% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-9.70%
Negative near-term dividend growth while QCOM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
16.07%
Our AR growth while QCOM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
9.29%
We show growth while QCOM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
19.47%
Asset growth 1.25-1.5x QCOM's 13.58%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
12.42%
BV/share growth above 1.5x QCOM's 5.32%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
16.35%
Debt shrinking faster vs. QCOM's 48.88%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-4.11%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
10.71%
We expand SG&A while QCOM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.